Campbell & CO Investment Adviser LLC Puma Biotechnology, Inc. Transaction History

Campbell & CO Investment Adviser LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$2.85 - $6.58 $58,140 - $134,232	-20,400 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$6.63 - $9.39 $135,252 - $191,556	20,400 New	20,400 $143,000
Q1 2020 Apr 29, 2020	SELL	$6.28 - $14.57 $104,342 - $242,080	-16,615 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$6.5 - $10.73 $107,997 - $178,278	16,615 New	16,615 $145,000
Q3 2019 Oct 16, 2019	SELL	$8.75 - $12.85 $171,832 - $252,348	-19,638 Closed	0 $0
Q2 2019 Jul 10, 2019	BUY	$12.3 - $35.76 $241,547 - $702,254	19,638 New	19,638 $250,000

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.